Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 1, Issue 3
December 2021
Issue Cover
All Issues
EISSN 2767-9764

Research Article

Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells
Austin T.K. Hoke; Michelle R. Padget; Kellsye P. Fabian; Anjali Nandal; Gary L. Gallia; Marijo Bilusic; Patrick Soon-Shiong; James W. Hodge; Nyall R. London, Jr.
View articletitled, Combinatorial Natural Killer Cell–based Immunotherapy Approaches Selectively Target Chordoma Cancer Stem Cells
Supplementary data
Open the PDF for in another window
Influence of Germline BRCA Genotype on the Survival of Patients with Triple-Negative Breast Cancer
Cynthia Villarreal-Garza; Ana S. Ferrigno; Alejandro Aranda-Gutierrez; Paul H. Frankel; Nora H. Ruel; Alan Fonseca; Steven Narod; Yanin Chavarri-Guerra; Erika Sifuentes; Maria Cristina Magallanes-Hoyos; Josef Herzog; Danielle Castillo; Rosa M. Alvarez-Gomez; Alejandro Mohar-Betancourt; Jeffrey N. Weitzel
View articletitled, Influence of Germline <em>BRCA</em> Genotype on the Survival of Patients with Triple-Negative Breast Cancer
Supplementary data
Open the PDF for in another window
Sex- and Mutation-Specific p53 Gain-of-Function Activity in Gliomagenesis
Nathan C. Rockwell; Wei Yang; Nicole M. Warrington; Max V. Staller; Malachi Griffith; Obi L. Griffith; Christina A. Gurnett; Barak A. Cohen; Dustin Baldridge; Joshua B. Rubin
View articletitled, Sex- and Mutation-Specific p53 Gain-of-Function Activity in Gliomagenesis
Supplementary data
Open the PDF for in another window
The ADAM17-directed Inhibitory Antibody MEDI3622 Antagonizes Radiotherapy-induced VEGF Release and Sensitizes Non–Small Cell Lung Cancer for Radiotherapy
Fabienne Tschanz; Sabine Bender; Irma Telarovic; Verena Waller; Roberto F. Speck; Martin Pruschy
View articletitled, The ADAM17-directed Inhibitory Antibody MEDI3622 Antagonizes Radiotherapy-induced VEGF Release and Sensitizes Non–Small Cell Lung Cancer for Radiotherapy
Supplementary data
Open the PDF for in another window
Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics
Yang Gao; Elena B. Kabotyanski; Jonathan H. Shepherd; Elizabeth Villegas; Deanna Acosta; Clark Hamor; Tingting Sun; Celina Montmeyor-Garcia; Xiaping He; Lacey E. Dobrolecki; Thomas F. Westbrook; Michael T. Lewis; Susan G. Hilsenbeck; Xiang H.-F. Zhang; Charles M. Perou; Jeffrey M. Rosen
View articletitled, Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics
Supplementary data
Open the PDF for in another window

Advertisement

Email alerts

eTOC Alert
Close Modal
PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated Macrophages
Phase I Trial of Intravenous Mistletoe Extract in Advanced Cancer
Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor–positive Breast Cancer
Statistical Assessment of Drug Synergy from In Vivo Combination Studies Using Mouse Tumor Models
  • Online ISSN 2767-9764

AACR Journals

 

 

  • Copyright © 2023 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept